Crinetics Pharmaceuticals
CRNX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Crinetics Pharmaceuticals(CRNX) predict that the Revenue is 10.73 M (+2873%), Beat estimate;the EBIT is -140.38 M (-26.01%), Miss estimate;the EPS is -1.23 (-18.27%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B2873.41%
0.01B2259.21%
+0.00B614.20%
EBITMiss expectations
-0.14B26.01%
-0.14B25.85%
-0.00B0.16%
EPSMiss expectations
-1.2318.27%
-1.222717.57%
-0.00730.70%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 4, 2026
Estimate Revenue14.87 M
Estimate EBIT-133.7 M
Estimate EPS-1.2059
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf